ConductScience.org, home

Comparison · NCT01446965-7f5a413c

Wearable Defibrillator vs Conventional Treatment: Sudden Death Mortality

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Wearable Defibrillator vs Conventional Treatment: Sudden Death Mortality. Trial comparisons, record NCT01446965-7f5a413c. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT01446965-7f5a413c

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.01640.01110.0241wilson
Risk in group 20.02440.01570.0378wilson
Risk difference, group 1 minus group 2-0.00802-0.02240.00363newcombe hybrid score
Risk ratio, group 1 over group 20.6720.3721.21log
Odds ratio, group 1 over group 20.6660.3651.22log
Number needed to treat, for one fewer participant with the outcome on Wearable Defibrillator than on Conventional Treatment125from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Wearable Defibrillator
subjects in the Device Group will receive a LifeVest® wearable cardioverter-defibrillator (manufacturer: ZOLL Medical Corporation) plus guideline-directed medical therapy for post-myocardial infarction patients~wearable defibrillator: LifeVest wearable defibrillator
251,524OG000
Group 2Conventional Treatmentsubjects in the Control Group will only receive guideline-directed medical therapy for post-myocardial infarction patients19778OG001

Outcome

Type
PRIMARY
Title
Sudden Death Mortality
Description
For witnessed deaths, sudden cardiac death will be defined as an unexpected non-traumatic, non-self-inflicted fatality in otherwise stable participants who die within one hour of the onset of the terminal symptoms. For unwitnessed deaths, participants will meet the definition of sudden death if they are found dead within 24 hours of being well, assuming there is no evidence of another cause of death during that time period.
Time frame
three months after myocardial infarction
Population
A total of 2302 participants were included in the analyses.

Source ClinicalTrials.gov

Trial

Title
Vest Prevention of Early Sudden Death Trial and VEST Registry
NCT number
NCT01446965
Phases
NA
Conditions
Myocardial Infarction, Ventricular Dysfunction, Sudden Death, Ventricular Tachycardia, Ventricular Fibrillation
Interventions
wearable defibrillator
Lead sponsor
University of California, San Francisco
Results first posted
2021-01-20

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT01446965-7f5a413c